Comparison of Cervical Laminectomy to Laminoplasty
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The objective of this study is to compare the clinical and radiographic outcomes of multi-level laminectomy to multi-level laminoplasty in the treatment of patients with cervical myelopathy or myeloradiculopathy. The hypothesis for the study is that the laminoplasty group is not inferior to the laminectomy group.
| Condition | Intervention |
|---|---|
|
Spinal Cord Diseases |
Device: Laminoplasty Procedure: laminectomy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Comparison of Cervical Laminectomy to Cervical Laminoplasty* in Patients With Cervical Myelopathy or Myeloradiculopathy Due to Multiple Level Cervical Spinal Canal Stenosis * ARCH™ Fixation System by SYNTHES |
- Neurological Status using the Modified Japanese Orthopaedic Assessment (mJOA) [ Time Frame: 12 months ] [ Designated as safety issue: No ]Success defined as mJOA recovery rate ≥ 0%
- Sagittal Angle [ Time Frame: 12 months ] [ Designated as safety issue: No ]Success defined as ≤ +15º (kyphosis) as indicated by a neutral lateral radiograph
- Incidence of Surgical Interventions [ Time Frame: up to 24 months ] [ Designated as safety issue: No ]Success defined as a lack of revision, removal or addition of supplemental fixation.
- Pain Scores on the Visual Analog Scale [ Time Frame: Up to 24 months ] [ Designated as safety issue: No ]
- Functional improvement using the Neck Disability Index (NDI) [ Time Frame: up to 24 months ] [ Designated as safety issue: No ]
- Quality of Life improvement using the SF-12 Scale [ Time Frame: up to 24 months ] [ Designated as safety issue: No ]
- Motor Deficit [ Time Frame: up to 24 months ] [ Designated as safety issue: No ]
- Reflex Evaluation [ Time Frame: up to 24 months ] [ Designated as safety issue: No ]
- Sensory Deficit [ Time Frame: up to 24 months ] [ Designated as safety issue: No ]
- Range of Motion [ Time Frame: up to 24 months ] [ Designated as safety issue: No ]
- Sagittal Canal Diameter [ Time Frame: up to 24 months ] [ Designated as safety issue: No ]
- Extent of Spinal Canal/Cord Decompression [ Time Frame: up to 24 months ] [ Designated as safety issue: No ]
| Enrollment: | 24 |
| Study Start Date: | January 2006 |
| Study Completion Date: | November 2010 |
| Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Laminectomy
Control
|
Procedure: laminectomy
standard procedure
|
|
Active Comparator: Laminoplasty
Treatment group
|
Device: Laminoplasty
Utilizing the ARCH Fixation System (Study device)
Other Name: ARCH Fixation System
|
Detailed Description:
Historically, cervical laminectomy has been proven to be effective in the treatment of symptomatic patients with cervical myelopathy. This standard procedure is employed to accomplish posterior decompression of the cervical spinal cord in patients with multi-level cervical spinal stenosis who have normal or near normal cervical spinal curvature and alignment without associated instability. Laminoplasty was developed in Japan as an alternative to the laminectomy procedure with the intent to reduce post-operative morbidity after dorsal cervical spinal cord decompression, neck pain and to maintain the relative stability of the cervical spine after multi-level decompression.
The goal of both the laminoplasty and laminectomy procedures is to provide spinal cord decompression by enlargement of the spinal canal. A potential benefit of laminoplasty compared to laminectomy is to preserve stability and range of motion of the cervical spine without complete disruption/removal of the posterior laminae, spinous processes and interspinous ligamentous structures. Various authors have described different laminoplasty techniques; all preserve the lamina and expand the size of the spinal canal by fixing the freed or partially freed lamina in a more posterior position.
The primary study hypothesis is that, patients treated with laminoplasty with ARCH fixation (Treatment Group) have clinical and radiographic outcomes as assessed by valid outcomes measures, is not inferior to patients treated with laminectomy (Control Group)
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria: All must be met for inclusion in the study.
- The patient must be at least 18 years of age and have no evidence of developmental anomaly of the cranial cervical junction and/or cervical spine
- The patient has the diagnosis of cervical myelopathy
- The myelopathy or myeloradiculopathy requires a posterior cervical decompression of the spinal canal involving two or more contiguous intervertebral levels including and between C3 and C7
- The patient signs the study informed consent form.
Exclusion Criteria:
- Primary symptoms and signs of cervical radiculopathy (only) without myelopathy.
- Presence of primary focal anterior compression of the cervical spinal cord.
- Ossification of the ligamentum flavum.
- Previous surgery of the cervical spine.
- Tumor, infection, or trauma of the cervical spine or cord.
- Segmental instability - Pregnant or interested in becoming pregnant during the study follow-up period.
- Known sensitivity to device materials.
- Currently being treated or intends to be treated postoperatively with other devices for the same disorder (e.g., electrical stimulation devices, pain control devices, etc.).
- Currently a participant in any other study related to the treatment of cervical spinal disorders.
- Prisoner
- Mentally incompetent, or unable to comply with the follow up regime
Contacts and Locations| United States, California | |
| Tower Orthopaedics | |
| Beverly Hills, California, United States, 90211 | |
| United States, Connecticut | |
| Yale University School of Medicine | |
| New Haven, Connecticut, United States, 06520 | |
| United States, Missouri | |
| Research Medical Center | |
| Kansas City, Missouri, United States, 64132 | |
| Washington University School of Medicine | |
| St. Louis, Missouri, United States, 63110 | |
| Principal Investigator: | Carl Lauryssen, MD | Tower Orthopaedics |
| Principal Investigator: | Daniel Riew, MD | Washington University School of Medicine |
More Information
Publications:
| Responsible Party: | Synthes USA HQ, Inc. |
| ClinicalTrials.gov Identifier: | NCT01324622 History of Changes |
| Other Study ID Numbers: | 2442 |
| Study First Received: | March 23, 2011 |
| Last Updated: | June 5, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Synthes USA HQ, Inc.:
|
Spinal Cord Diseases Myelopathy Myeloradiculopathy Laminectomy Laminoplasty |
Additional relevant MeSH terms:
|
Spinal Cord Diseases Central Nervous System Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013